Navigating US & EP Patent Law for Startups – avoiding the common pitfalls

Are you interested in patent strategy for biotech startups? Join us for an engaging online discussion on the dos and don’ts of drafting, prosecuting, and litigating patents in the United States and Europe. The crucial differences between these jurisdictions are very often overlooked, leading to costly disputes and strategic missteps.

We’ll explore high-impact cases where US and EP courts issued contradictory rulings on the same facts, highlighting how an early, dual-jurisdictional strategy could have altered the outcome. Discussion of these cases will also serve as a springboard for discussion of how differing legal nuances can shape planning, innovation and competition. For example, the continuing battle over CRISPR technology, and the Sanofi v. Amgen decisions, among others, will be used to demonstrate how jurisdictional considerations can impact application content and filing strategy.

What you’ll learn:

• Key differences in patentability, litigation, and enforcement
• Real-world case studies of divergent US vs. EP court decisions
• Practical strategies for strengthening IP portfolios across jurisdictions

Don’t miss this chance to sharpen your global IP strategy and avoid common pitfalls.